BARCLAYS PRESENTS: The 39 Most Innovative Public Companies In America

Photo: shyb

With U.S. corporates sitting on ever growing stockpiles of cash, companies have to find new businesses and projects to put capital to work.Barclays analyst Gavin Smith is out with a list on the 39 firms he believes can successfully innovate their way forward. 

Smith looked at five criteria when assembling the list: 

  1. Research and Development intensity average greater than 1 per cent over past five years (intensity is defined as R&D divided by sales)
  2. Proven record of turning innovation into profitability
  3. Net Debt over EBITDA under 3x to limit funding constraints
  4. Premium of price-to-earnings ratio below 50 per cent to limit overpaying for an equity
  5. Market cap over $1 billion

Barclays focused on firms with low debt financing because R&D projects are often hit-or-miss. High debt financing requires a firm to generate stable profits to pay off interest expenses — something R&D projects cannot always guarantee.

Two industries clearly dominate Smith’s list: technology and healthcare firms.

“We believe this screen is particularly relevant given the high levels of cash on firms’ balance sheets,” Smith says. “The screen is a good starting point for understanding which firms have success at deploying cash on innovative projects.”

Netflix Inc.

Ticker: NFLX

R&D Intensity: 7 per cent

Net Debt/EBITDA: -0.9

Barclays Performance Score: 2.5

Company Description: Netflix offers DVD and Blu-ray rental by mail, as well as video streaming in the US. It is headquartered in Los Gatos, California.

Source: Barclays

WMS Industries Inc.

Ticker: WMS

R&D Intensity: 13 per cent

Net Debt/EBITDA: -0.2

Barclays Performance Score: 2.2

Company Description: WMS manufactures and distributes games to the gambling industry.

Source: Barclays

General Mills Inc.

Ticker: GIS

R&D Intensity: 2 per cent

Net Debt/EBITDA: 2.3

Barclays Performance Score: 2.0

Company Description: General Mills sells consumer food products including cereal, snacks, vegetables, and yogurt.

Source: Barclays

Abbott Laboratories

Ticker: ABT

R&D Intensity: 10 per cent

Net Debt/EBITDA: 0.8

Barclays Performance Score: 2.2

Company Description: Abbott is a major pharmaceutical and medical devices company, with offerings in a variety of markets including arthritis and cholesterol.

Source: Barclays

Becton Dickinson and Co.

Ticker: BDX

R&D Intensity: 6 per cent

Net Debt/EBITDA: 0.7

Barclays Performance Score: 2.0

Company Description: Becton Dickinson manufactures and sells medical devices.

Source: Barclays

Gilead Sciences Inc.

Ticker: GILD

R&D Intensity: 14 per cent

Net Debt/EBITDA: -0.6

Barclays Performance Score: 2.6

Company Description: Gilead is a leading biotechnology firm with drugs in the HIV/AIDS, liver disease and hepatitis markets.

Source: Barclays

Hologic Inc

Ticker: HOLX

R&D Intensity: 6 per cent

Net Debt/EBITDA: 1.2

Barclays Performance Score: 2.0

Company Description: Hologic manufactures surgical equipment and other products for the breast health, diagnostics, and skeletal health markets.

Source: Barclays

Illumina Inc.

Ticker: ILMN

R&D Intensity: 19 per cent

Net Debt/EBITDA: -1.2

Barclays Performance Score: 2.3

Company Description: Illumina manufactures tools to analyse genetic variation.

Source: Barclays

Intuitive Surgical Inc.

Ticker: ISRG

R&D Intensity: 8 per cent

Net Debt/EBITDA: -1.4

Barclays Performance Score: 2.6

Company Description: Intuitive manufactures the da Vinci Surgical Systems which uses precision incisions and a better range of motion.

Source: Barclays

Life Technologies Corp.

Ticker: LIFE

R&D Intensity: 10 per cent

Net Debt/EBITDA: 1.5

Barclays Performance Score: 2.1

Company Description: Life is involved in genomics research and proteomics and cell biology applications.

Source: Barclays

Medtronic Inc.

Ticker: MDT

R&D Intensity: 9 per cent

Net Debt/EBITDA: 1.3

Barclays Performance Score: 2.1

Company Description: Medtronic markets and manufactures medical devices for diabetes and heart disease, among other conditions.

Source: Barclays

Qiagen NV

Ticker: QGEN

R&D Intensity: 11 per cent

Net Debt/EBITDA: 0.0

Barclays Performance Score: 2.0

Company Description: Qiagen is involved in reanalytical sample preparation and linked molecular assay solutions.

Source: Barclays

Quality Systems Inc.

Ticker: QSII

R&D Intensity: 6 per cent

Net Debt/EBITDA: -0.9

Barclays Performance Score: 2.6

Company Description: Quality Systems markets healthcare IT systems.

Source: Barclays

ResMed Inc.

Ticker: RMD

R&D Intensity: 7 per cent

Net Debt/EBITDA: -1.5

Barclays Performance Score: 2.1

Company Description: ResMed manufactures and develops sleep-disorder treatments and products.

Source: Barclays

St Jude Medical

Ticker: STJ

R&D Intensity: 12 per cent

Net Debt/EBITDA: 1.1

Barclays Performance Score: 2.2

Company Description: St Jude manufactures cardiovascular and neurostimulation medical devices.

Source: Barclays

Techne Corp.

Ticker: TECH

R&D Intensity: 9 per cent

Net Debt/EBITDA: -0.8

Barclays Performance Score: 2.1

Company Description: Techne manufactures and sells biotechnology products and hematology controls.

Source: Barclays

Varian Medical Systems

Ticker: VAR

R&D Intensity: 7 per cent

Net Debt/EBITDA: -0.7

Barclays Performance Score: 2.2

Company Description: Varian manufactures cancer treatment technologies, including radiotherapy.

Source: Barclays

West Pharmaceutical Services Inc

Ticker: WST

R&D Intensity: 2 per cent

Net Debt/EBITDA: 1.3

Barclays Performance Score: 1.6

Company Description: West develops packaging and systems for injectable drugs, including the caps and sealants used on vials.

Source: Barclays

Emerson Electric Co

Ticker: EMR

R&D Intensity: 2 per cent

Net Debt/EBITDA: 0.7

Barclays Performance Score: 2.1

Company Description: Emerson designs and markets IT systems and offers engineering services to clients in the industrial world.

Source: Barclays

HEICO Corp.

Ticker: HEI

R&D Intensity: 3 per cent

Net Debt/EBITDA: 1.0

Barclays Performance Score: 2.2

Company Description: HEICO manufactures FAA approved replacement aircraft parts.

Source: Barclays

Lincoln Electric Holdings

Ticker: LECO

R&D Intensity: 1 per cent

Net Debt/EBITDA: -0.7

Barclays Performance Score: 1.9

Company Description: Lincoln manufactures welding products.

Source: Barclays

Triumph Group

Ticker: TGI

R&D Intensity: 1 per cent

Net Debt/EBITDA: 2.2

Barclays Performance Score: 2.1

Company Description: Triumph designs and manufactures aerostructures and aircraft components.

Source: Barclays

Woodward Inc.

Ticker: WWD

R&D Intensity: 6 per cent

Net Debt/EBITDA: 1.3

Barclays Performance Score: 2.3

Company Description: Woodward manufactures energy and fluid movement systems.

Source: Barclays

Apple Inc.

Ticker: AAPL

R&D Intensity: 3 per cent

Net Debt/EBITDA: -2.1

Barclays Performance Score: 2.8

Company Description: Apple designs, manufactures and sells consumer electronic goods, including desktop computers, laptops, mobile phones and tablets.

Source: Barclays

ADTRAN Inc.

Ticker: ADTN

R&D Intensity: 16 per cent

Net Debt/EBITDA: -0.8

Barclays Performance Score: 2.2

Company Description: Adtran provides networking and communication equipment for the last mile of the telecommunication network.

Source: Barclays

Advent Software Inc.

Ticker: ADVS

R&D Intensity: 18 per cent

Net Debt/EBITDA: -1.3

Barclays Performance Score: 1.7

Company Description: Advent markets software that automates data movement between investment management firms.

Source: Barclays

Broadcom Corp

Ticker: BRCM

R&D Intensity: 31 per cent

Net Debt/EBITDA: -3.2

Barclays Performance Score: 1.9

Company Description: Broadcom manufactures chips for both wireless and wired devices.

Source: Barclays

Cree Inc.

Ticker: CREE

R&D Intensity: 12 per cent

Net Debt/EBITDA: -3.5

Barclays Performance Score: 1.7

Company Description: Cree manufactures light emitting diode screens and products.

Source: Barclays

Cisco Systems

Ticker: CSCO

R&D Intensity: 13 per cent

Net Debt/EBITDA: -2.5

Barclays Performance Score: 2.2

Company Description: Cisco sells Internet protocol communication equipment and networking devices.

Source: Barclays

Dolby Laboratories

Ticker: DLB

R&D Intensity: 10 per cent

Net Debt/EBITDA: -2.2

Barclays Performance Score: 2.6

Company Description: Dolby sells audio equipment to movie theatres and production crews.

Source: Barclays

FLIR Systems

Ticker: FLIR

R&D Intensity: 9 per cent

Net Debt/EBITDA: -0.5

Barclays Performance Score: 2.6

Company Description: FLIR manufactures sensors for a variety of industries, including digital cameras and imaging.

Source: Barclays

Google Inc.

Ticker: GOOG

R&D Intensity: 13 per cent

Net Debt/EBITDA: -3.0

Barclays Performance Score: 2.7

Company Description: Google Inc. is an Internet search technology corporation. Google hosts and develops dozens of products, but generates profits primarily through search advertising.

Source: Barclays

NetApp Inc.

Ticker: NTAP

R&D Intensity: 14 per cent

Net Debt/EBITDA: -3.7

Barclays Performance Score: 2.1

Company Description: NetApp offers network storage and data management, with headquarters in Sunnyvale, CA.

Source: Barclays

Nuance Communications

Ticker: NUAN

R&D Intensity: 13 per cent

Net Debt/EBITDA: 1.8

Barclays Performance Score: 1.8

Company Description: Nuance provides speech, imaging and keypad solutions.

Source: Barclays

Oracle Corp.

Ticker: ORCL

R&D Intensity: 12 per cent

Net Debt/EBITDA: -0.9

Barclays Performance Score: 2.7

Company Description: Oracle Corporation is a technology corporation specializing in enterprise software products.

Source: Barclays

Synaptics Inc

Ticker: SYNA

R&D Intensity: 15 per cent

Net Debt/EBITDA: -3.5

Barclays Performance Score: 2.4

Company Description: Synaptics designs user interfaces for electronic devices and is a co-engineering partner on Windows 8.

Source: Barclays

TriQuint Semiconductor Inc.

Ticker: TQNT

R&D Intensity: 16 per cent

Net Debt/EBITDA: -1.1

Barclays Performance Score: 1.8

Company Description: TriQuint produces radio frequency solutions for communication applications.

Source: Barclays

VistaPrint NV

Ticker: VPRT

R&D Intensity: 11 per cent

Net Debt/EBITDA: 0.6

Barclays Performance Score: 2.4

Company Description: VistaPrint sells printing services to small businesses.

Source: Barclays

Monsanto Co.

Ticker: MON

R&D Intensity: 11 per cent

Net Debt/EBITDA: -0.4

Barclays Performance Score: 2.3

Company Description: Monsanto markets and manufactures agriculture products to farmers.

Source: Barclays

The Top Performing Global Markets

Those are some of Barclays top U.S. picks.
But these are the top performing global markets >

NOW WATCH: Money & Markets videos

Want to read a more in-depth view on the trends influencing Australian business and the global economy? BI / Research is designed to help executives and industry leaders understand the major challenges and opportunities for industry, technology, strategy and the economy in the future. Sign up for free at research.businessinsider.com.au.